Vida Health Gains $28.5 Million Funding, Launches Solution With Capital Rx 

Vida Health, which offers a virtual cardiometabolic care platform, received $28.5 million in financing, The round was led by investors including General Atlantic, Ally Bridge, Canvas Ventures, and Hercules Capital. The company said it would use the funding to scale and pursue growth opportunities. Separately, Vida Health reported it is partnering with pharmacy benefit manager and pharmacy benefit administrator Capital Rx to launch Rx Activate using JUDI, Capital Rx’s proprietary enterprise health platform.  

The companies said Rx Activate would use the JUDI platform to offer Vida’s virtual cardiometabolic solutions, providing consumers access to resources and options to . . .